HPV16 PsV infection decreases following SLPI treatment or anti-annexin A2 antibody inhibition of A2t. by Andrew W. Woodham (140650)

Contaminant levels (ng/g wt) in the sera of obese JCR rats treated with vehicle (V) or high dose (H) NCM with (E) or without (W) co-exposure to ethanol. by Ryan J. Mailloux (50825)

Subjects: “…mitochondrial ATP synthase subunit ATP 5A…”

JHMV N1347A has decreased replication in the olfactory bulbs of mice. by Catherine M. Kerr (21492574)

Promoter reporter studies for SF-1 regulating the human <i>BDNF</i> promoter I and comparative studies of specific <i>NR5A1</i> mutations on <i>BDNF</i> promoter activity. by Jana Malikova (615672)

Subjects:

ALK2 AON-induced exon skipping decreased BMP signaling in 2H11 endothelial cells. by SongTing Shi (430629)

Damsin (D) and ambrosin (A) treatment decreases the CSC population. by Wendy Soria Sotillo (4408105)

Gene expression of <i>Hdac7</i> WT, HET and KO osteoclast cultures. by Melissa Stemig (723969)

Promoter reporter studies for reported <i>NR5A1</i> mutations by Jana Malikova (615672)

Subjects:

PDGF-BB maintains Bcl2/Bax ratio and decreases caspase-3 activation induced by Tat and morphine. by Shaily Malik (226661)

“…<p>(A) Human neurons were treated with 100 ng/ml Tat and/or 100 nM morphine for 12 hours with or without pre-treatment with 40 ng/ml PDGF-BB. …”

Mutation of four arginine residues in P34 leads to a decrease in binding between P34 and L5. by Anyango D. Kamina (4034165)

BoNT/A (3.5 U/kg) decreases orofacial formalin-induced dural extravasation. by Boris Filipović (336089)

Blocking C5L2 decreased C5a-primed neutrophils expression of membrane-bound PR3 (mPR3). by Jian Hao (160736)

Differentially regulated genes in cells with increased or decreased expression of miR-106a-5p. by Feng Zhi (294362)

“…(C) A Venn diagram of the overlap of altered genes with increased or decreased miR-106a-5p expression. …”

Over-expression of ANX RLKs inhibits pollen germination, pollen tube growth, and decreases male transmission efficiency. by Aurélien Boisson-Dernier (490023)

GCase activity is significantly decreased in the brain and liver of the homozygous <i>GBA1</i> D409V KI mouse model at 4, 8, and 12 months of age. by Nicole K. Polinski (10947787)

“…In whole brain homogenate (A,C) and liver homogenate (B,D), GCase activity is significantly decreased in the <i>GBA1</i> D409V KI homozygous (HOM) mice as compared to C57Bl/6 wild type (WT) mice (n = 7/group). …”

Inhibition of PKC or Rho protein kinase decreases Ad5 wild type replication <i>in vitro</i>. by Alice Liu (4814415)

Brain and liver GCase activity are significantly decreased in heterozygous <i>GBA1</i> D409V KI mice, with varying differences in glucosphingolipid lipids in brain and liver. by Nicole K. Polinski (10947787)

“…(A-B) GCase levels as assessed by the CBE/4-MU method are significantly decreased in the het <i>GBA1</i> D409V KI mice at 5 months of age in both brain (A) and liver (B). …”

APB5, but not APA5, decreases proliferating cell numbers in inter-alveolar spaces of lungs. by Masami Kishi (6167105)

Expression of MHC II decreased in old Gas7-deficient soleus while MHC I expression increased. by Bo-Tsang Huang (162584)

Cerebral edema and clinical signs of CM are decreased in α_D ^-/- mice infected with <i>P</i>. <i>berghei</i> ANKA. by Isaclaudia G. de Azevedo-Quintanilha (8173734)